Search clinical trials for: CL184
Total 92 results
-
Crucell Holland BVCompleted
-
Crucell Holland BVCompleted
-
ExelixisCompletedGlioblastoma MultiformeUnited States
-
ExelixisCompletedAstrocytic TumorsUnited States, Canada
-
ExelixisCompletedLymphoma | Cancer | Thyroid CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
ExelixisCompletedHealthy | Hepatic ImpairmentUnited States
-
ExelixisCompletedHealthy | Renal ImpairmentUnited States
-
Dana-Farber Cancer InstituteCompletedCarcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Massachusetts General HospitalCompletedLung Cancer | Solid Tumor (Not Breast or Prostate Cancers)United States
-
University of Michigan Rogel Cancer CenterExelixisTerminatedProstate Cancer MetastaticUnited States
-
Dana-Farber Cancer InstituteCompleted
-
ExelixisCompletedThyroid CancerFrance, United Kingdom, United States, Spain, Austria, Israel, Portugal, Saudi Arabia, Netherlands, Greece, Canada, Brazil, Chile, Poland, Italy, Russian Federation, Sweden, Germany, Denmark, India, Switzerland, Belgium, Korea, Republic... and more
-
University of Alabama at BirminghamCompletedNeurofibromatosis | Plexiform Neurofibromas | NF1United States
-
Dana-Farber Cancer InstituteExelixisTerminatedSkin Cancer | Merkel Cell CarcinomaUnited States
-
ExelixisActive, not recruitingMedullary Thyroid CancerAustralia, France, Israel, Spain, Russian Federation, Netherlands, Hungary, Korea, Republic of, Croatia, Italy, Canada, Poland, Romania, Sweden
-
ExelixisCompletedCancer | Solid TumorsUnited States, Taiwan, Belgium, Israel, United Kingdom
-
Bristol-Myers SquibbCompleted
-
ExelixisCompletedCancer | NSCLC | Solid TumorsJapan
-
TakedaCompletedAdvanced Hepatocellular CarcinomaJapan
-
TakedaCompletedAdvanced Renal Cell CarcinomaJapan
-
Edwin Posadas, MDCompletedProstate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); Prostate Cancer FoundationTerminatedRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
ExelixisIpsenActive, not recruitingDifferentiated Thyroid CancerHong Kong, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Czechia, France, Germany, Hungary, Israel, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Russian Federation, Spain, Taiwan, ... and more
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); ExelixisActive, not recruitingRenal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8United States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell AdenocarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingSoft Tissue Sarcoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Osteosarcoma | Ewing Sarcoma | Recurrent Renal Cell Carcinoma | Refractory Malignant Solid Neoplasm | Rhabdomyosarcoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Malignant Solid Neoplasm | Recurrent Osteosarcoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Ewing Sarcoma | Recurrent Osteosarcoma | Stage III Osteosarcoma AJCC v7 | Stage IV Osteosarcoma AJCC v7 | Stage IVA Osteosarcoma AJCC v7 | Stage IVB Osteosarcoma AJCC v7 | Metastatic Osteosarcoma | Metastatic Ewing Sarcoma | Unresectable Ewing Sarcoma | Unresectable OsteosarcomaFrance
-
Baptist Health South FloridaExelixisRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Unresectable Adrenal Gland Pheochromocytoma | Unresectable Paraganglioma | Regional Adrenal Gland PheochromocytomaUnited States
-
ExelixisCompletedHepatocellular CarcinomaBelgium, Hong Kong, Korea, Republic of, Canada, France, Taiwan, United States, Germany, Spain, United Kingdom, Singapore, Australia, Italy, Netherlands, Poland, Turkey, Ireland, New Zealand, Romania
-
ExelixisCompletedRenal Cell Carcinoma | Papillary Thyroid Cancer | Follicular Thyroid Cancer | Huerthle Cell Thyroid CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Recurrent Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer AJCC v7 | Stage IVA Uterine Corpus Cancer AJCC v7 | Stage IVB Uterine Corpus Cancer AJCC v7 | Endometrial Adenosquamous... and other conditionsUnited States, Canada
-
National Cancer Institute (NCI)CompletedRefractory Malignant Solid Neoplasm | Recurrent Melanoma | Recurrent Malignant Solid Neoplasm | Recurrent Thyroid Gland Carcinoma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Thyroid Gland Medullary CarcinomaUnited States, Canada
-
University of ChicagoNorthShore University HealthSystemCompletedRecurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate CancerUnited States
-
University of UtahExelixisActive, not recruitingBladder Cancer | Metastatic Urothelial CarcinomaUnited States
-
ExelixisCompletedCarcinoma, Non-Small-Cell LungUnited States
-
National Cancer Institute (NCI)CompletedHIV Infection | Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Solid NeoplasmUnited States
-
Fox Chase Cancer CenterExelixisRecruitingMetastatic Renal Cell Carcinoma | Clear-cell Metastatic Renal Cell CarcinomaUnited States
-
ExelixisCompletedRenal Cell CarcinomaUnited States, Belgium, Spain, Taiwan, Canada, Germany, Korea, Republic of, France, Austria, Chile, Australia, Hungary, Russian Federation, Italy, Turkey, Netherlands, Sweden, United Kingdom, Czechia, Ireland, Slovakia, Argentina, D... and more
-
Mark SteinBristol-Myers Squibb; ExelixisRecruitingCYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition (Cyto-KIK)Kidney Cancer | Renal Cell CarcinomaUnited States
-
ExelixisCompletedGlioblastoma | Gliosarcoma | Giant Cell GlioblastomaUnited States
-
Yousef ZakhariaUniversity of Iowa; ExelixisRecruitingAdvanced Metastatic MelanomaUnited States
-
University of WashingtonExelixisTerminatedAdvanced Hepatocellular Carcinoma | BCLC Stage B Hepatocellular Carcinoma | BCLC Stage C Hepatocellular CarcinomaUnited States
-
M.D. Anderson Cancer CenterExelixisWithdrawnHepatocellular Carcinoma | Liver CancerUnited States
-
ExelixisActive, not recruitingRenal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Urothelial Carcinoma | Differentiated Thyroid Cancer | Gastroesophageal... and other conditionsUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; ExelixisCompletedLocally Advanced Hepatocellular CarcinomaUnited States
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
Providence Health & ServicesBristol-Myers Squibb; ExelixisActive, not recruitingRefractory Cutaneous MelanomaUnited States
-
Massachusetts General HospitalExelixisActive, not recruitingBreast CancerUnited States